The Joe Arrington Cancer Research and Treatment Center at Covenant Health provides comprehensive cancer care close to home for adult and pediatric patients in West Texas and Eastern New Mexico. It is accredited by the Foundation for the Accreditation of Cellular Therapy as a tertiary center for malignant hematology. The center offers patients personalized cellular therapy pathways, including autologous stem cell transplants and the latest in bispecific T-cell immunotherapy. Through the adult and Children’s Oncology Group clinical research trials, patients gain access to novel therapies and prevention trials. Equipped with the region’s only Gamma Knife, the center stands at the forefront of cutting-edge technology. Additionally, the center made advances in targeted radioactive therapy with the FDA-approved Pluvicto for advanced prostate cancer. It has also been recognized for quality with accreditation from American Society of Radiation Oncology. Through a powerful research collaboration with Renton, Wash.-based Providence, the center is on the frontlines of developing new treatments, participating in clinical trials and working toward cures. From recent successes in immunotherapy to the emerging promise of precision medicine and new insights into the healing benefits of early palliative care, the cancer center is leveraging advancements in cancer prevention, diagnosis, treatment and survival for its patients.
